Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics Secures $250M Credit

NEW YORK – NeoGenomics said after the close of the market on Thursday that it has entered into a new $250 million, five-year senior secured credit agreement.

The agreement consists of a $100 million revolving credit facility, a $100 million initial term loan, and a $50 million delayed-draw term loan, which is available for 18 months.

NeoGenomics received the initial term loan facility in full upon the closing of the deal, along with access to the revolving credit facility. The Fort Myers, Florida-based provider of cancer genetic testing services said it has used $100 million of the proceeds to retire its prior outstanding term loan and revolving credit facility. The remaining funds are expected to support inorganic growth opportunities and general corporate purposes.

In May, the firm announced a $148.8 million public offering of 7 million shares of its common stock. In combination with that, "our new larger credit agreement provides NeoGenomics significant flexibility to opportunistically grow through M&A and invest in other key corporate initiatives," NeoGenomics CFO Sharon Virag said in a statement.

PNC Capital Markets and PNC Bank, National Association were the lead arranger and administrative agent for the deal.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.